[Federal Register Volume 78, Number 104 (Thursday, May 30, 2013)]
[Notices]
[Page 32392]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) and the Health Resources and Services Administration 
(HRSA) announce the following meeting of the aforementioned committee:

    Times and Dates: 8:00 a.m.-5:30 p.m., June 18, 2013; 8:00 a.m.-
2:30 p.m., June 19, 2013.
    Place: CDC Corporate Square, Building 8, Conference Room 1-ABC, 
8 Corporate Boulevard, Atlanta, Georgia 30329, Telephone: (404) 639-
8317.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people. This 
meeting is also accessible by teleconference. Toll-free +1 (866) 
718-4584, Participant code: 8484551.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, 
CDC and the Administrator, HRSA, regarding activities related to 
prevention and control of HIV/AIDS, Viral Hepatitis and other STDs, 
the support of health care services to persons living with HIV/AIDS, 
and education of health professionals and the public about HIV/AIDS, 
Viral Hepatitis and other STDs.
    Matters To Be Discussed: Agenda items include: (1) STD clinical 
preventive services in primary care setting and integrating STD 
screening and treatment services in HIV care settings); (2) The test 
and cure era for hepatitis C: The public health response to rising 
hepatitis C mortality; The impact of new therapies on health 
outcomes; and Building care capacity to increase access to hepatitis 
C virus (HCV) therapy; (3) HIV Medical Monitoring Project: follow up 
on Institute of Medicine (IOM) report and other Affordable Care Act 
(ACA) issues; (4) Recommendations for new HIV diagnostic laboratory 
testing algorithms; and (5) CHAC Workgroups Update.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, Centers 
for Disease Control and Prevention, National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road NE., 
Mailstop E-07, Atlanta, Georgia 30333, Telephone (404) 639-8317.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-12857 Filed 5-29-13; 8:45 am]
BILLING CODE 4163-18-P